Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Mira, Y; Todoli, J; Alonso, R; Mico, ML; Vaya, A; Ferrando, F; Estelles, A; Villa, P; Aznar, J
   Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: Two cases
   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
   
   Y. Mira et al., "Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: Two cases", CL APPL T-H, 7(3), 2001, pp. 234-237
2. Junghans, U; Seitz, RJ; Wittsack, HJ; Aulich, A; Siebler, M
   Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: Report of four cases
   RADIOLOGY
   
   U. Junghans et al., "Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: Report of four cases", RADIOLOGY, 221(3), 2001, pp. 795-801
3. Grau, E; Real, E; Medrano, J; Pastor, E; Selfa, S
   Recurrent venous thromboembolism in a Spanish population: Incidence, risk factors, and management in a hospital setting
   THROMBOSIS RESEARCH
   
   E. Grau et al., "Recurrent venous thromboembolism in a Spanish population: Incidence, risk factors, and management in a hospital setting", THROMB RES, 96(5), 1999, pp. 335-341
4. Kohda, N; Tani, T; Nakayama, S; Adachi, T; Marukawa, K; Ito, R; Ishida, K; Matsumoto, Y; Kimura, Y
   Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery
   THROMBOSIS RESEARCH
   
   N. Kohda et al., "Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery", THROMB RES, 96(4), 1999, pp. 261-268
5. Rebello, SS; Huang, JB; Saito, K; Saucedo, JF; Bates, ER; Lucchesi, BR
   Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   S.S. Rebello et al., "Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion", EUR J PHARM, 374(3), 1999, pp. 399-410
6. Huang, JB; Rebello, SS; Rosenberg, LA; Kaneko, M; Sakurama, T; Lucchesi, BR
   Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   J.B. Huang et al., "Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model", EUR J PHARM, 366(2-3), 1999, pp. 203-213
7. REBELLO SS; HUANG JB; SAITO K; LUCCHESI BR
   IN-VIVO EFFICACY OF SM-20302, A GP IIB IIIA RECEPTOR ANTAGONIST, CORRELATES WITH EX-VIVO PLATELET INHIBITION IN HEPARINIZED BLOOD BUT NOT IN CITRATED BLOOD/
   Arteriosclerosis, thrombosis, and vascular biology
   
   S.S. Rebello et al., "IN-VIVO EFFICACY OF SM-20302, A GP IIB IIIA RECEPTOR ANTAGONIST, CORRELATES WITH EX-VIVO PLATELET INHIBITION IN HEPARINIZED BLOOD BUT NOT IN CITRATED BLOOD/", Arteriosclerosis, thrombosis, and vascular biology, 18(6), 1998, pp. 954-960
8. Chicaud, P; Rademakers, JR; Millet, J
   The beneficial effect of a beta-D-xyloside, iliparcil, in the prevention of postthrombolytic rethrombosis in the rat
   HAEMOSTASIS
   
   P. Chicaud et al., "The beneficial effect of a beta-D-xyloside, iliparcil, in the prevention of postthrombolytic rethrombosis in the rat", HAEMOSTASIS, 28(6), 1998, pp. 313-320
9. EICK B; HAUDE M; ALTMANN C; LIU F; CASPARI G; LEISCHIK R; ERBEL R
   SUCCESSFUL TREATMENT OF A LARGE INTRACORO NARY THROMBUS WITH UROKINASE AND A CHIMERICAL MONOCLONAL PLATELET-AGGREGATION INHIBITOR
   Deutsche Medizinische Wochenschrift
   
   B. Eick et al., "SUCCESSFUL TREATMENT OF A LARGE INTRACORO NARY THROMBUS WITH UROKINASE AND A CHIMERICAL MONOCLONAL PLATELET-AGGREGATION INHIBITOR", Deutsche Medizinische Wochenschrift, 122(22), 1997, pp. 709-715
10. PIETRUCHA T; GOLANSKI J; BAJ Z; TCHORZEWSKI H; GREGER J; WATALA C
    FLOW CYTOMETRIC ANALYSIS OF THE PREVENTION OF PLATELET ACTIVATION BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND STREPTOKINASE
    Fibrinolysis
    
    T. Pietrucha et al., "FLOW CYTOMETRIC ANALYSIS OF THE PREVENTION OF PLATELET ACTIVATION BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND STREPTOKINASE", Fibrinolysis, 10(4), 1996, pp. 239-248
11. STRONY J; SONG A; RUSTERHOLTZ L; ADELMAN B
    AURINTRICARBOXYLIC ACID PREVENTS ACUTE RETHROMBOSIS IN A CANINE MODELOF ARTERIAL THROMBOSIS
    Arteriosclerosis, thrombosis, and vascular biology
    
    J. Strony et al., "AURINTRICARBOXYLIC ACID PREVENTS ACUTE RETHROMBOSIS IN A CANINE MODELOF ARTERIAL THROMBOSIS", Arteriosclerosis, thrombosis, and vascular biology, 15(3), 1995, pp. 359-366
12. SUDO Y; KILGORE KS; LUCCHESI BR
    MONOCLONAL-ANTIBODY [7E3 F(AB')(2)] PREVENTS ARTERIAL BUT NOT VENOUS RETHROMBOSIS
    Journal of cardiovascular pharmacology
    
    Y. Sudo et al., "MONOCLONAL-ANTIBODY [7E3 F(AB')(2)] PREVENTS ARTERIAL BUT NOT VENOUS RETHROMBOSIS", Journal of cardiovascular pharmacology, 26(2), 1995, pp. 241-250
13. ROTE WE; DAVIS JH; MOUSA SA; REILLY TM; LUCCHESI BR
    ANTITHROMBOTIC EFFECTS OF DMP-728, A PLATELET GPIIB IIIA RECEPTOR ANTAGONIST, IN A CANINE MODEL OF ARTERIAL THROMBOSIS/
    Journal of cardiovascular pharmacology
    
    W.E. Rote et al., "ANTITHROMBOTIC EFFECTS OF DMP-728, A PLATELET GPIIB IIIA RECEPTOR ANTAGONIST, IN A CANINE MODEL OF ARTERIAL THROMBOSIS/", Journal of cardiovascular pharmacology, 23(4), 1994, pp. 681-689
14. SAKAMOTO T; OGAWA H; YASUE H; ODA Y; KITAJIMA S; TSUMOTO K; MIZOKAMI H
    PREVENTION OF ARTERIAL REOCCLUSION AFTER THROMBOLYSIS WITH ACTIVATED PROTEIN-C - COMPARISON WITH HEPARIN IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS
    Circulation
    
    T. Sakamoto et al., "PREVENTION OF ARTERIAL REOCCLUSION AFTER THROMBOLYSIS WITH ACTIVATED PROTEIN-C - COMPARISON WITH HEPARIN IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS", Circulation, 90(1), 1994, pp. 427-432
15. FEIGEN LP; NICHOLSON NS; KING LW; CAMPION JG; TJOENG FS; PANZERKNODLE SG
    SC-49992, A MIMETIC OF THE PEPTIDE ARGININE-GLYCINE-ASPARTIC ACID-PHENYLALANINE THAT BLOCKS PLATELET-AGGREGATION, ENHANCES RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR-INDUCED THROMBOLYSIS AND PREVENTS REOCCLUSIONIN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS
    The Journal of pharmacology and experimental therapeutics
    
    L.P. Feigen et al., "SC-49992, A MIMETIC OF THE PEPTIDE ARGININE-GLYCINE-ASPARTIC ACID-PHENYLALANINE THAT BLOCKS PLATELET-AGGREGATION, ENHANCES RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR-INDUCED THROMBOLYSIS AND PREVENTS REOCCLUSIONIN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS", The Journal of pharmacology and experimental therapeutics, 267(3), 1993, pp. 1191-1197
16. FRADE LJG; AVELLO AG
    THROMBOLYSIS - STATE-OF-THE-ART - NEED OF ANTITHROMBOTIC THERAPY
    Revista Clinica Espanola
    
    L.J.G. Frade e A.G. Avello, "THROMBOLYSIS - STATE-OF-THE-ART - NEED OF ANTITHROMBOTIC THERAPY", Revista Clinica Espanola, 193(2), 1993, pp. 88-92